© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
AAIC 2025 to Feature Lecanemab Data on Long-Term Efficacy, Real-World Use, and Maintenance Dosing
July 22, 2025
Eisai will present four-year safety and efficacy data, real-world use patterns, and findings on a new subcutaneous formulation for maintenance treatment in early Alzheimer disease.
Why Cognitive Screening Should Be Routine in Primary Care: A Conversation With Anna Chodos, MD, MPH
July 22, 2025
In recognition of World Brain Day, Anna Chodos, MD, discusses why early detection of cognitive decline must become standard practice—and how PCPs can take simple, effective steps to make that happen.
What is Precision Neurocognition? David J Libon, PhD, Provides an Overview
July 22, 2025
Libon, a professor at the New Jersey Institute for Successful Aging at Rowan University, says the refined approach to cognitive assessment is widely available.
World Brain Day 2025: 9 Studies on Alzheimer Disease and Related Dementias Chosen for Primary Care
July 22, 2025
World Brain Day is celebrated on July 22 every year. In recognition Patient Care has summarized 9 notable studies of key interest to primary care for quick review.
Monu Khanna, MD, on the Unique Role of Primary Care in Managing Cardiometabolic Disease
July 21, 2025
Dr Khanna discusses how PCPs can use patient relationships to tailor lifestyle advice and manage obesity-related cardiometabolic disease.
Needle-Free Epinephrine Nasal Spray Shows Promise in Pediatric Food Allergy Anaphylaxis
July 21, 2025
Neffy, a needle-free epinephrine nasal spray, showed promise as a safe alternative for treating anaphylaxis in children with food allergies in a phase 3 trial.
Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings
July 21, 2025
Atopic dermatitis flares should be factored in to an assessment of disease severity and prognosis, the authors note, and a threshold established for acceptable frequency.
17 Adult Vaccines: Who to Consider for Each
July 21, 2025
A review of 4 factors can help primary care clinicians with an initial decision about adult vaccination: health, age, lifestyle, and occupation (HALO).
Roche's Investigational Anti-IL-33/ST2 Antibody for COPD Misses Phase 3 Primary Endpoint
July 21, 2025
Astegolimab did result in a statistically significant reduction of annualized exacerbation rates in a similar phase 2b trial, but the result was not replicated in phase 3.
FDA Advisory Committee Casts Nearly Unanimous Vote Against Otsuka's PTSD Combination
July 21, 2025
The FDA advisory committee overwhelmingly voted against Otsuka's PTSD treatment, citing insufficient evidence from clinical trials for approval.